Research Paper Volume 15, Issue 20 pp 11389—11411
Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma
Figure 2. Development of ICDRG-based molecular subtypes for GC. (A) The PCA pattern of ICDRG-based molecular subtypes. (B) Clinical prognosis outcome of GC samples in ICDRG-based subgroups. (C, D) GSVA plot shows the dramatically altered KEGG signaling pathways between ICDRG-based subgroups. (E) ESTIMATE assessment of GC samples in ICDRG cluster A, B and C. (F) Immune infiltration investigation via ssGSEA algorithm.